These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29570919)

  • 1. De novo CMV-associated collapsing focal segmental glomerulosclerosis in a kidney transplant recipient.
    Patel AM; Zenenberg RD; Goldberg RJ
    Transpl Infect Dis; 2018 Jun; 20(3):e12884. PubMed ID: 29570919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collapsing focal segmental glomerulosclerosis induced by cytomegalovirus: A case report].
    Grèze C; Garrouste C; Kemeny JL; Philipponnet C; Aniort J; Heng AÉ
    Nephrol Ther; 2018 Feb; 14(1):50-53. PubMed ID: 29191574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMV-associated collapsing focal segmental glomerulosclerosis after kidney transplant in a pediatric patient.
    Parr MFE; Hidalgo G; Goldstein MJ; Batal I; Lieberman KV; Amoruso MR; Baer AZ; Jain NG
    Pediatr Transplant; 2023 Aug; 27(5):e14535. PubMed ID: 37128132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal segmental glomerulosclerosis associated with acute cytomegalovirus infection in a renal transplant.
    Wynd E; Stewart A; Burke J
    Pediatr Transplant; 2019 Sep; 23(6):e13538. PubMed ID: 31271240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
    Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A
    Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal segmental glomerulosclerosis after renal transplantation.
    Shimizu A; Higo S; Fujita E; Mii A; Kaneko T
    Clin Transplant; 2011 Jul; 25 Suppl 23():6-14. PubMed ID: 21623907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report.
    Green CB; O'Riordan A; Griffiths P; Haque T
    J Clin Virol; 2016 Jul; 80():24-6. PubMed ID: 27131599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
    Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new mutation in the human cytomegalovirus UL97 gene may confer ganciclovir resistance in Chinese kidney transplant recipients.
    Zhang Y; Zhao Z; Sun J; Cao G; Zhao F; Hu J; Liu L; Ji Y
    Arch Virol; 2013 Jan; 158(1):247-50. PubMed ID: 23011309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
    West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B
    Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disease by CMV resistant to Ganciclovir. Should plasma valganciclovir levels be monitored in high risk patients?].
    Sola E; Vega E; Gutiérrez C; López V; Cabello M; Burgos D; González Molina M; Siles J
    Nefrologia; 2009; 29(2):180-1. PubMed ID: 19396331
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
    Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
    J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
    Hantz S; Michel D; Fillet AM; Guigonis V; Champier G; Mazeron MC; Bensman A; Denis F; Mertens T; Dehee A; Alain S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1580-3. PubMed ID: 15793144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collapsing glomerulopathy in a renal transplant recipient: potential molecular mechanisms.
    Dogan E; Ghanta M; Tanriover B
    Ann Transplant; 2011; 16(2):113-6. PubMed ID: 21716195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
    Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
    Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus ischemic colitis and transverse myelitis in a renal transplant recipient.
    Gorsane I; Aloui S; Letaif A; Hadhri R; Haouala F; Frih A; Dhia NB; Elmay M; Skhiri H
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):309-14. PubMed ID: 23538355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panresistant cytomegalovirus in a kidney transplant recipient.
    Yost SE; Echeverria A; Jie T; Kaplan B
    Pharmacotherapy; 2014 Jan; 34(1):e1-3. PubMed ID: 24277702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.